A Clinically Feasible Diagnostic Electrochemical Micronano Motors Biosensor Built on Miniature Swimmer for Multiplex Detection and Grading of Breast Cancer Biomarkers.
Ya ZhangXiaofang LiuYing XuQun WangJingzhou HouChangjun HouDanqun HuoPublished in: Analytical chemistry (2024)
Estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), and Ki67 are four crucial biomarkers used in the clinical diagnosis of breast cancer. Accurate detection of these biomarkers is essential for an effective diagnosis and treatment. MOF-based micronano motors (MOFtors) are promising for various applications, including environmental remediation, targeted nanosurgery, and biomarker detection. This paper presents a clinically feasible diagnostic electrochemical micronano motor biosensor, built on a miniature swimmer, for the multiplex detection and grading of breast cancer biomarkers. We designed a biosensor, named MOFtor-MSEM, incorporating aptamers and antibodies functionalized on SiO 2 @Co-Fe-MOF, which acts as a miniature swimmer in solution. The SiO 2 @Co-Fe-MOF serves as the body, while complementary double-chain-linked antibodies function as paddles. In a homogeneous solution, when a positive voltage is applied to the working electrode, the electrostatic interaction between the neutral SiO 2 @Co-Fe-MOF and the negatively charged complementary double-linked antibody causes the antibody to move toward the electrode and then regress due to water resistance. This back-and-forth motion propels the miniature swimmer, enabling it to move the target analyte through the solution. The sensor features an automatic "sample-amplifying signal-output" process, achieving simultaneous signal amplification and output of four electrochemical signals on a single nanomaterial, a significant challenge in electrochemical sensing. The biosensor boasts a short detection time of 40 min, compared to approximately 1 week for current clinical tissue testing. Additionally, the bioplatform selectively detects HER2, ER, Ki67, and PR in the range of 0-1500 pg/mL, with detection limits of 0.01420, 0.03201, 0.01430, and 0.01229 pg/mL, respectively.
Keyphrases
- label free
- gold nanoparticles
- real time pcr
- estrogen receptor
- epidermal growth factor receptor
- loop mediated isothermal amplification
- metal organic framework
- quantum dots
- endothelial cells
- tyrosine kinase
- ionic liquid
- neoadjuvant chemotherapy
- rectal cancer
- clinical trial
- high throughput
- lymph node
- solid state
- study protocol
- molecularly imprinted
- pluripotent stem cells
- molecular dynamics simulations
- locally advanced
- mass spectrometry